免费看av的,欧美一性一乱一交一视频多男,日韩影院一区,羞羞视频一区二区,国产专区中文字幕,精品免费av,男女av免费观看

EN
×
EN
  • 業(yè)務(wù)咨詢

    中國(guó):

    Email: marketing@medicilon.com.cn

    業(yè)務(wù)咨詢專線:400-780-8018

    (僅限服務(wù)咨詢,其他事宜請(qǐng)撥打川沙總部電話)

    川沙總部電話: +86 (21) 5859-1500

    海外:

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在線留言×
點(diǎn)擊切換

搜索結(jié)果包含 solid 的內(nèi)容

Jul 02,2025
MCL1抑制劑在多種實(shí)體瘤和血液腫瘤模型中顯示抗腫瘤效果,本研究中藥效實(shí)驗(yàn)通過(guò)美迪西進(jìn)行
CDX studies were performed at Shanghai Medicilon (OS-RC-2). All studies were performed in accordance with animal research guidelines from the Shanghai Medicilon Inc.
查看更多
MCL1抑制劑在多種實(shí)體瘤和血液腫瘤模型中顯示抗腫瘤效果,本研究中藥效實(shí)驗(yàn)通過(guò)美迪西進(jìn)行
Jul 06,2023
PTX-HSN是一種高效納米系統(tǒng),具有較高耐受劑量,可將PTX遞送至卵巢癌并增強(qiáng)主動(dòng)腫瘤靶向性。此研究中所有體內(nèi)實(shí)驗(yàn)均通過(guò)美迪西進(jìn)行
Paclitaxel-loaded hyaluronan solid nanoemulsions (PTX-HSNs) were successfully fabricated for the delivery of PTX to improve ovarian cancer treatment via active tumor targeting. The in vivo #toxicity,
查看更多
PTX-HSN是一種高效納米系統(tǒng),具有較高耐受劑量,可將PTX遞送至卵巢癌并增強(qiáng)主動(dòng)腫瘤靶向性。此研究中所有體內(nèi)實(shí)驗(yàn)均通過(guò)美迪西進(jìn)行
Jun 28,2023
CAR-T療法主要針對(duì)白血病與惡性淋巴瘤,本研究中構(gòu)建沉默PD-1的shRNA載體質(zhì)粒,測(cè)序后質(zhì)粒的鑒定通過(guò)美迪西進(jìn)行
Chimeric antigen receptor T cells (CAR-T) immunotherapy has shown promising clinical results in the treatment of leukemia and lymphoma, but the effectiveness is limited for solid tumors. The shRNA vector plasmid that silences PD-1 and preparation of CAR i
查看更多
CAR-T療法主要針對(duì)白血病與惡性淋巴瘤,本研究中構(gòu)建沉默PD-1的shRNA載體質(zhì)粒,測(cè)序后質(zhì)粒的鑒定通過(guò)美迪西進(jìn)行
×
搜索驗(yàn)證
點(diǎn)擊切換